Ann Intern Med. 2002 Jan 15;136(2):157-60. doi: 10.7326/0003-4819-136-2-200201150-00015.
This statement summarizes the recommendation of the third U.S. Preventive Services Task Force (USPSTF) for aspirin for the primary prevention of cardiovascular events, as well as the supporting scientific evidence. The complete information on which this statement is based, including evidence tables and references, can be found in a companion article in this issue. Copies of this document, the summary of the evidence, and the systematic evidence review can be obtained through the USPSTF Web site (http://www.ahrq.gov/clinic/uspstfix.htm) and in print through the Agency for Healthcare Research and Quality Publications Clearinghouse (800-358-9295).
本声明总结了美国预防服务工作组（USPSTF）第三次关于阿司匹林用于心血管事件一级预防的建议以及相关科学证据。本声明所依据的完整信息，包括证据表和参考文献，可在本期的一篇配套文章中找到。本文件、证据摘要及系统证据综述的副本可通过USPSTF网站（http://www.ahrq.gov/clinic/uspstfix.htm）获取，也可通过医疗保健研究与质量机构出版物信息中心（800-358-9295）以印刷品形式获取。
